Mycoplasma hominis

The Mycoplasma Hominis home test is a confidential laboratory test that detects the presence of Mycoplasma hominis in genital or urinary samples using sensitive methods such as PCR and/or culture performed by accredited Dubai laboratories. The test identifies bacterial DNA or viable organisms to confirm infection, information that can be critical because M. hominis is associated with pelvic inflammatory disease, bacterial vaginosis, adverse pregnancy outcomes, and can contribute to infertility or recurrent genitourinary symptoms.

This service is suitable for individuals with abnormal genital discharge, pelvic pain, recurrent vaginitis, couples undergoing fertility evaluation, or anyone advised by a clinician to rule out Mycoplasma infection. Home sampling provides privacy and convenience while samples are processed in certified Dubai labs for fast, accurate reporting; test results should be reviewed with a healthcare professional to guide appropriate, targeted antibiotic therapy given that mycoplasmas lack a cell wall and require specific antimicrobial choices.

• Mycoplasma hominis (PCR) Detection
• Mycoplasma hominis Culture
• Antibiotic Susceptibility / Resistance Profile
• Semiquantitative Organism Load

• Persistent or abnormal genital discharge
• Pelvic or lower abdominal pain
• Recurrent vaginitis or unexplained urinary symptoms
• Infertility or recurrent pregnancy loss evaluation
• Prior to or during assisted reproductive procedures when clinically indicated

• Confidential at‑home sample collection
• Analysis by DHA/DOH‑accredited Dubai laboratories
• Rapid, sensitive PCR-based detection for accurate diagnosis
• Information to guide targeted antibiotic therapy and follow-up
• Support for reproductive health and fertility care decisions

• At‑home vaginal/urethral swab or first‑void urine collection (self-collected or by trained sampler)
• Avoid antibiotics or topical vaginal medications for 2 weeks prior to sampling
• Refrain from sexual intercourse, douching, or vaginal products 24–48 hours before collection
• Inform the laboratory if you are pregnant or currently receiving treatment